Background:
This study compared the health outcomes of abortion by vaginal misoprostol tablets and suction curettage in the first trimester of pregnancy.
Jentashapir Journal of Cellular and Molecular Biology
This study compared the health outcomes of abortion by vaginal misoprostol tablets and suction curettage in the first trimester of pregnancy.
In this study, 220 pregnant women (under 14 weeks gestational age) who candidate for termination of pregnancy (due to fetal or maternal reasons) were divided into the treatment and surgery groups. In the medical abortion group, 600 g vaginal misoprostol was given, then 36 hours later if needed this dose was repeated. However, if the remains of the pregnancy were observed by ultrasound 1 week after the initial dose, the curettage was done. Suction curettage was used in the surgical abortion group.
In general, 79% of treatment group had a complete abortion without the need for surgical abortion. In all subjects of surgical groups, all products of pregnancy with surgical curettage were fully discharged. The mean satisfaction from amount of bleeding in the drug and medical abortion groups was 80% and 84%, respectively with no statistical difference.
© 2014, Jentashapir Journal of Cellular and Molecular Biology. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Behnoud F, Noori N, Ghasemi M, Dashipour A. Comparison of the Effect of Vaginal Misoprostol with and Without Laminaria on Ripening or Cervical Preparation in the Second Trimester Abortion: A Randomized Clinical Trial Study. Zahedan J Res Med Sci. 2023;25(1):e121027. doi: https://doi.org/10.5812/zjrms-121027
Vahid Roudsari F, Ayati S, Saghafy N, Shakeri M. Misoprostol Alone or in Combination with Methotrexate for Termination of Pregnancy at First Trimester. Iran J Pharm Res. 2010;9(1):e126037. doi: https://doi.org/10.22037/ijpr.2010.841
Jahedbozorgan T, rahmati N, Zonoubi Z. Comparison of therapeutic and side effects of misoprostol moistened with normal saline and acetic acid in induced abortion. J Inflamm Dis. 2024;18(5):e155857. doi:
Movahed F, Mohammad Abrahim G. Comparison of vaginal suppository and intravenous PGE2 in termination of pregnancy at midtrimester. J Inflamm Dis. 2024;7(4):e154985. doi:
Pourhoseini SA, Niroumand S, Akbari A, Mirteimouri M, Akhlaghi F, et al. Comparing the Effects of Misoprostol/Letrozole and Misoprostol/Placebo on Medical Abortion Success Rate: A Randomized Clinical Trial. Shiraz E-Med J. 2023;24(4):e131460. doi: https://doi.org/10.5812/semj-131460
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):